Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule

Highlights • Immune responses of infants were assessed 1 month after the national UK schedule. • Infants could receive any of three meningococcal C conjugate vaccines at 3 and 4 months. • Responses were lower after CRM-conjugated followed by tetanus-conjugated MenC vaccine. • Conjugate vaccines with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2015-01, Vol.33 (5), p.648-655
Hauptverfasser: Ladhani, Shamez N, Andrews, Nick J, Waight, Pauline, Hallis, Bassam, Matheson, Mary, England, Anna, Findlow, Helen, Bai, Xilian, Borrow, Ray, Burbidge, Polly, Pearce, Emma, Goldblatt, David, Miller, Elizabeth
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • Immune responses of infants were assessed 1 month after the national UK schedule. • Infants could receive any of three meningococcal C conjugate vaccines at 3 and 4 months. • Responses were lower after CRM-conjugated followed by tetanus-conjugated MenC vaccine. • Conjugate vaccines with different carrier proteins may not be interchangeable. • When possible children should receive conjugate vaccines with the same carrier protein.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2014.12.018